Ligand Pharmaceuticals
LGND
#3601
Rank
โ‚น326.87 B
Marketcap
โ‚น16,608
Share price
-1.93%
Change (1 day)
58.79%
Change (1 year)

Revenue for Ligand Pharmaceuticals (LGND)

Revenue in 2025 (TTM): โ‚น21.88 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น22.56 Billion. In 2024 the company made a revenue of โ‚น14.33 Billion an increase over the revenue in the year 2023 that were of โ‚น10.93 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ligand Pharmaceuticals from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น21.88 B52.65%
2024 โ‚น14.33 B31.16%
2023 โ‚น10.93 B-23.6%
2022 โ‚น14.30 B-30.64%
2021 โ‚น20.62 B51.3%
2020 โ‚น13.63 B58.95%
2019 โ‚น8.57 B-51.22%
2018 โ‚น17.58 B95.15%
2017 โ‚น9.00 B21.66%
2016 โ‚น7.40 B54.96%
2015 โ‚น4.77 B16.84%
2014 โ‚น4.09 B35.19%
2013 โ‚น3.02 B76.05%
2012 โ‚น1.71 B8.16%
2011 โ‚น1.58 B50.64%
2010 โ‚น1.05 B-41.63%
2009 โ‚น1.80 B37.63%
2008 โ‚น1.31 B159.45%
2007 โ‚น0.50 B-84.73%
2006 โ‚น3.31 B-55.06%
2005 โ‚น7.37 B7.37%
2004 โ‚น6.86 B6.86%
2003 โ‚น6.42 B38.66%
2002 โ‚น4.63 B25.81%
2001 โ‚น3.68 B61.81%
2000 โ‚น2.27 B28.14%
1999 โ‚น1.77 B136.05%
1998 โ‚น0.75 B-62.96%
1997 โ‚น2.03 B52.75%
1996 โ‚น1.33 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚น3.231 T 14,217.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚น2.31 B-89.76%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น3.804 T 16,757.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น5.770 T 25,467.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.640 T 24,891.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น5.338 T 23,551.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.315 T 19,019.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚น990.26 B 4,287.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.278 T 36,578.70%๐Ÿ‡บ๐Ÿ‡ธ USA